pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,554 catalysts · 5,256 phase readout · 2,298 8k filing · 321 pdufa · 255 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: 8k filing×type: phase readout×clear all
type
  • phase readout5,256
  • 8k filing2,298
  • pdufa321
  • earnings255
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07536867: Comparison of Serratus Posterior Superior Intercostal Plane Block and Rhomboid Intercostal Block in Patients Undergoing Breast Cancer Surgery

Sponsor: Antalya City Hospital. Phase: NA. Conditions: Breast Cancer, Lymph Node Dissection, Postoperative Pain, Mastectomy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07408167: AI Models in Clinical Pathology Diagnosis: A Multicenter RCT

Sponsor: Nanfang Hospital, Southern Medical University. Phase: NA. Conditions: Pathology Foundation Model

full page →ctgov ↗
›RECRUITINGphase readoutNCT07347600: A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

Sponsor: Hoffmann-La Roche. Phase: . Conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05008900: Timing of Post-prostatectomy PSMA Imaging

Sponsor: University Health Network, Toronto. Phase: PHASE2. Conditions: Prostate Cancer, Prostatectomy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02863107: Young-Onset Colorectal Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Colon Adenocarcinoma, Colorectal Carcinoma, Rectal Adenocarcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07015892: Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial

Sponsor: Instituto de Investigación Biomédica de Salamanca. Phase: PHASE3. Conditions: Small Cell Lung Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07099092: Causal Mechanisms of Odor-Guided Behavior in Humans

Sponsor: National Institute on Drug Abuse (NIDA). Phase: EARLY_PHASE1. Conditions: Normal Physiology

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05689671: Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma

Sponsor: Nikolaj Frost MD. Phase: PHASE4. Conditions: Non-Small Cell Lung Cancer Metastatic

full page →ctgov ↗
›RECRUITINGphase readoutNCT06481644: Asia Pediatric Intensive Care Epidemiology and Outcomes Study

Sponsor: KK Women's and Children's Hospital. Phase: . Conditions: Pediatrics, Intensive Care Unit, Critical Illness

full page →ctgov ↗
›COMPLETEDphase readoutNCT07563634: Long-term Safety and Efficacy of Adjunctive Brivaracetam in Chinese Patients With Uncontrolled Focal Epilepsy

Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Phase: PHASE3. Conditions: Epilepsy, Focal

full page →ctgov ↗
›RECRUITINGphase readoutNCT07277309: Promoting Recovery After Brain Injury Using Focused Ultrasound

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Consciousness Disorders, Disorders of Consciousness Due to Severe Brain Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT07625709: EFFECT OF TRANEXAMIC ACID ON PERIOPERATIVE BLOOD LOSS IN REAMED INTRAMEDULLARY NAILING OF DIAPHYSEAL FEMORAL AND TIBIAL FRACTURES: A PROSPECTIVE COMPARATIVE STUDY

Sponsor: Kathmandu University School of Medical Sciences. Phase: NA. Conditions: Blood Loss, Postoperative, Blood Loss, Surgical, Femoral Fracture, Tibial Fracture

full page →ctgov ↗
›RECRUITINGphase readoutNCT07361809: The Analgesic Efficacy and Safety of Desvenlafaxine in Patients With Herpes Zoster

Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Herpes Zoster, Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07476599: The OB-WELL Project, a Randomized Controlled Trial of an Internet-Based Self-Help System for Psychological Support in Obesity

Sponsor: Catholic University of the Sacred Heart. Phase: NA. Conditions: Obesity (BMI > 35)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05989399: Evaluation of Circulating Neutrophils in Antisynthetase Syndrome

Sponsor: Central Hospital, Nancy, France. Phase: . Conditions: Antisynthetase Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07450599: A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.

Sponsor: Bayer. Phase: PHASE2. Conditions: High-Risk Localized Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06694363: New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Activated PI3K Delta Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT06140693: A Comparison of Affective Responses During Continuous and Interval Exercise

Sponsor: University of Stirling. Phase: NA. Conditions: Health Behavior

full page →ctgov ↗
›COMPLETEDphase readoutNCT06164106: Feasibility Trial of a Single Session of Crisis Response Planning for Youth at High Risk for Suicide

Sponsor: Ohio State University. Phase: NA. Conditions: Suicide Prevention

full page →ctgov ↗
›RECRUITINGphase readoutNCT07395206: Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders

Sponsor: Charite University, Berlin, Germany. Phase: NA. Conditions: Psychosis, Psychotic Disorders, Primary Psychotic Disorders, Schizophrenia Spectrum Disorders, Schizophrenia, Schizoaffective Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT05902104: CGM-Assisted Management of PN

Sponsor: Boston Children's Hospital. Phase: . Conditions: Intestinal Failure, Hypoglycemia, Hyperglycemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07580014: Choroidal and Retinal Features in PACD and POAG on OCT and OCTA

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University. Phase: . Conditions: Glaucoma, OCTA, Choroid

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02965716: Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Melanoma, Recurrent Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma

full page →ctgov ↗
›TERMINATEDphase readoutNCT02738606: Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Metastatic Malignant Neoplasm in the Lung, Recurrent Colorectal Carcinoma, Resectable Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7

full page →ctgov ↗
›COMPLETEDphase readoutNCT05193084: Remote Monitoring of Ambulatory Intravenous Diuretics in Heart Failure

Sponsor: Heartfelt Technologies. Phase: . Conditions: Heart Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT07410533: Analysis of Factors Associated With the Efficacy of 595-nm Pulsed Dye Laser Treatment for Rosacea

Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: NA. Conditions: Pulsed Dye Laser, Rosacea

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07569133: Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease

Sponsor: Ho-Won Lee. Phase: NA. Conditions: Parkinson's Disease, Depression

full page →ctgov ↗
›COMPLETEDphase readoutNCT07333781: Effects of Communication Training for Mental Health Occupational Therapy Interns

Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Communication

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07364981: Gaze Contingent Attentional Reinforcement in Major Depressive Disorder

Sponsor: Tel Aviv University. Phase: NA. Conditions: Major Depressive Disorder (MDD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT04712565: Hard and Soft Tissue Maintenance Around Implants With a Sloped Configuration

Sponsor: Medical University of Graz. Phase: NA. Conditions: Tooth Loss

full page →ctgov ↗
›COMPLETEDphase readoutNCT01047865: Type 1 Diabetes Recurrence in Pancreas Transplants

Sponsor: University of Miami. Phase: . Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›COMPLETEDphase readoutNCT04864067: No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer

Sponsor: Servicio de Salud Metropolitano Sur Oriente. Phase: PHASE2. Conditions: Rectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06613100: Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Sponsor: Amgen. Phase: PHASE1. Conditions: Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06934200: Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels

Sponsor: Johns Hopkins University. Phase: PHASE2. Conditions: Food Hypersensitivity

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05935800: The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates

Sponsor: Methodist Health System. Phase: . Conditions: Frailty, Sarcopenia, COVID-19

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07638800: Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult Trial Participants

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05955300: Nutrition and Movement to Improve Quality of Life With Knee Osteoarthritis

Sponsor: St. Pölten University of Applied Sciences. Phase: NA. Conditions: Osteo Arthritis Knee

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07609836: Caudal Dexamethasone - Bupivacaine in Neonates

Sponsor: Ain Shams University. Phase: NA. Conditions: We Are Studying the Effects of Caudal Dexamethasone in Neonates Undergoing Inguinal Hernia Repair

full page →ctgov ↗
›COMPLETEDphase readoutNCT03262636: Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)

Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Brain Tumor, Primary, Brain Tumor, Recurrent

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07349836: Application of mRNA Immunotherapy Technology in EB Virus Related Diseases

Sponsor: Xinqiao Hospital of Chongqing. Phase: EARLY_PHASE1. Conditions: EBV-associated Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT07583836: DELAYED VERSUS EARLY SURGICAL DECOMPRESSION FOR TRAUMATIC SPINAL CORD INJURY

Sponsor: Fauji Foundation Hospital. Phase: . Conditions: Traumatic Spinal Cord Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT07367971: Drug-Drug Interaction Study of ABP-671 in Gout Patients

Sponsor: Atom Therapeutics Co., Ltd. Phase: PHASE1. Conditions: Gout Chronic, Gout, DDI (Drug-Drug Interaction)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07380334: A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors

Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT06777134: Relationship Between Pelvic Floor Dysfunctions and Lower Limb Strength and Activation in MS Patients

Sponsor: Berivan Beril Kılıç. Phase: . Conditions: Multiple Sclerosis, Pelvic Floor Dysfunction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07568509: Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

Sponsor: Massachusetts General Hospital. Phase: EARLY_PHASE1. Conditions: Arginine Vasopressin Deficiency, Oxytocin Deficiency, Pediatric Disease, Hypopituitarism

full page →ctgov ↗
›RECRUITINGphase readoutNCT07004699: Comparison of Two Ventilation Methods During Endoscopy of the Pharynx, Larynx and Oesophagus

Sponsor: Poitiers University Hospital. Phase: NA. Conditions: Oxygen Inhalation Therapy Endoscopy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05553132: A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects

Sponsor: Daniel B. F. Saris. Phase: PHASE1. Conditions: Cartilage Defect

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07640932: Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer

Sponsor: Yonsei University. Phase: PHASE2. Conditions: Carcinoma, Small Cell Lung

full page →ctgov ↗
›COMPLETEDphase readoutNCT06216132: Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults

Sponsor: Akyso Therapeutics, LLC. Phase: PHASE1. Conditions: Opioid Use Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06438263: A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

Sponsor: Amgen. Phase: PHASE1. Conditions: Atopic Dermatitis

full page →ctgov ↗
← prev
page 105 of 152
next →